Dr. Sheri Yolanda Prentiss explores the challenges patients face in accessing lymphedema compression garments following ...

Diabetic retinopathy affects 30 lakh Indians and can lead to vision loss. Advanced therapies include costly injections ...

Astrasentan becomes the first and only endothelin A receptor antagonist to focus on proteinuria reduction in primary ...

The U.S. Food and Drug Administration (FDA) previously granted orphan drug designation to deucrictibant for the treatment of bradykinin-mediated angioedema in March 2022.

US-based biopharmaceutical company KalVista Pharmaceuticals has finished enrolling subjects in its KONFIDENT-KID trial of ...

The changing therapeutic landscape for urticaria, angioedema, and anaphylaxis is evidenced by emerging treatments reported at ...

The first in-human trials of an implantable device shows favorable safety and effectiveness in the treatment of corneal edema. The first in-human trials for an artificial lamellar implant (EndoArt, ...

and Pharming Group NV – aims to improve outcomes for HAE patients and advance clinical research for new treatment options to benefit patients around the globe. Hereditary angioedema is a rare genetic ...

So, in addition to its original U.S. label for the treatment of diabetic macular edema in patients who have been previously treated with a course of corticosteroids and did not have a clinically ...

Treatment with donanemab (Kisunla ... the frequency of ARIA was 32%. ARIA with edema or effusions (ARIA-E) occurred in 24.4% of donanemab-treated patients in the placebo-controlled trials and ...